Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma
Clinical trial NCT02235701 · COMPLETED
Trial details
- NCT number
- NCT02235701
- Sponsor
- ImmunityBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-02
- Primary completion
- 2018-05-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.